Thursday, the Food and Drug Administration named drugmakers, including Celgene Corp., Johnson & Johnson, Gilead Sciences, and Novartis AG, as companies that are potentially blocking access to samples of their drugs to delay generic competition. Generic drugmakers may not be able to develop...
The Food and Drug Administration took the aggressive step of publicly exposing drug companies it says may be gaming the system by improperly blocking competition... Wall Street Journal - USAlso reported by •SeattlePI.com •USATODAY.com •Seattle Times •Reuters •SFGate
According to a report by Gizmodo, the United States' Food and Drug Administration published a list of pharmaceutical companies that it accuses of impeding the development of generic drugs. The list,.. Source: Wochit -
According to a report by Business Insider, the FDA is calling out drugmakers it claims are 'gaming' the system as a way of obstructing generic competition. The US Food and Drug Administration published.. Source: Wochit -